Overview

Sufentanil and ANI

Status:
Recruiting
Trial end date:
2025-01-04
Target enrollment:
Participant gender:
Summary
Analgesia Nociception Index (ANI) has been proposed for the evaluation of the nociception-antinociception balance in the perioperative period. In pediatric patients with Moyamoay disease, where the management of analgesia may be rendered difficult by pharmacological changes, we hypothesised that the monitoring of analgesia with ANI would reduce intraoperative opioid consumption during EDAS surgery.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Sufentanil